Mortality Increased Among Hospitalized Patients with Cirrhosis Before and Following Different Waves of the COVID-19 Pandemic.
Patrick A TwohigKyle ScholtenMakayla SchisselKevin BrittanJason BarbarettaKaeli SamsonLynette SmithMark MailliardThoetchai Bee PeeraphatditPublished in: Digestive diseases and sciences (2023)
Inpatient mortality among patients with cirrhosis has increased during the COVID-19 pandemic compared to before COVID-19. Although COVID-19 infection may have had a small direct pathologic effect on the natural history of cirrhotic liver disease, it is more likely that other factors are impacting this population.